Comparisons between ticagrelor and clopidogrel for the secondary prevention of
stroke in CYP2C19 loss-of-function carriers have not been extensively performed.
Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA Read More »
The role of CYP2C19 genotyping to guide antiplatelet therapy following ischemic stroke or transient ischemic attack Please download the file to learn more.
Acute stroke management module final Please download the file to learn more.
csbpr7 Acute Stroke Management Module Read More »
NCGS 2023 Acute care Please download the file to learn more.
NCGS 2023 Acute care Read More »
European Stroke Organisation expedited recommendation for the use of short term dual antiplatelet therapy early after minor stroke and high risk TIA Please download the file to learn more.
Association between CYP2C19 Polymorphisms and Outcomes in Cerebral Endovascular Therapy Please download the file to learn more.
Association between CYP2C19 Polymorphisms and Outcomes in Cerebral Endovascular Therapy Read More »
NICE Clopidogrel genotype testing after ischaemic stroke or transient ischaemic attack Please download the file to learn more.
NICE Clopidogrel genotype testing after ischaemic stroke or transient ischaemic attack Read More »
Genotype Guided Antiplatelet Therapy Versus Standard Therapy for Patients with Coronary Artery Disease An Updated Systematic Review and Meta Analysis Please download the file to learn more.
Guided vs conventional anti-platelet therapy for patients with acute coronary syndrome A meta-analysis of randomized controlled trials Please download the file to learn more.
META JACC Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy Please download the file to learn more.
© 2024 Genomadix, the Genomadix logo and all product names are the property of Genomadix or its licensors. All rights reserved.
